Fungi are adapting to warmer climates due to climate change, making them stronger and more resistant to antifungal drugs. Human body temperature has historically provided natural immunity, but as fungi evolve to withstand higher temperatures, this barrier could be defeated, increasing the risk of fungal infections.
Candida auris is a drug-resistant fungus that emerged in 2009 and has since spread globally. It is particularly dangerous for immunocompromised individuals and is difficult to eradicate in healthcare settings. Its simultaneous appearance on three continents, unrelated to each other, suggests a link to global warming, making it a warning sign of fungal adaptation to higher temperatures.
Most fungi cannot survive or replicate at human body temperatures, which average around 97 degrees Fahrenheit. This natural thermal barrier prevents fungal infections in healthy individuals. However, as fungi adapt to warmer environments and human body temperatures decrease slightly, this protection could diminish.
Fungi are essential for nutrient recycling in ecosystems, breaking down organic matter like fallen trees. However, they are also major pathogens for crops, causing significant agricultural losses. For example, fungal pathogens affect wheat, rice, and bananas, threatening global food security.
Fungi are biochemically similar to humans, making it difficult to develop drugs that target fungi without harming human cells. Additionally, antifungal resistance is rising, and the most effective antifungal drug, amphotericin B, was developed in 1957 and has significant toxicity issues.
Fungi have promising applications in biotechnology, including the development of biodegradable materials like fungal leather, radiation shielding for space exploration, and innovative air conditioning systems. They are also being explored for water filtration and construction materials, potentially revolutionizing industries.
Climate change is causing fungi to adapt to higher temperatures, which could allow them to overcome the thermal barrier that protects humans. Warmer environments also enable fungi to reassort their DNA, potentially leading to increased virulence and drug resistance.
Developing a fungal vaccine is challenging because the at-risk population, such as immunocompromised individuals, may not respond well to vaccines. While vaccines are possible, they require significant societal effort and investment, which is currently lacking compared to other diseases.
Fungi have caused catastrophic declines in wildlife, such as the extinction of frog species due to chytrid fungus and the decimation of bat populations from white-nose syndrome. These ecological disruptions have cascading effects, including increased pesticide use and potential impacts on human health.
During the AIDS epidemic in the 1980s, opportunistic fungal infections, such as pneumocystis, were a major cause of death for HIV patients. This highlighted the deadly potential of fungi in immunocompromised individuals and spurred research into fungal diseases.
Five years after COVID became a global pandemic, could another health crisis be on our horizon? According to scientists who study diseases, the possibility of a fungal pandemic—the subject of science fiction TV shows like “The Last of Us,” could be more of a reality, thanks to climate change and our warming planet. As fungi are adapting to warmer climates, they are becoming increasingly stronger and more resistant against the drugs we have to fight them.
Arturo Casadevall is one of the scientists who is warning against fungi's powerful potential. He's a professor of microbiology and immunology at the Johns Hopkins’ Bloomberg School of Public Health and the author of the new book, What If Fungi Win? He explains why fungi are becoming a growing public health threat, and what tools we have to protect ourselves from a future fungal outbreak.